PEI-JEN LOUJacky Lam, W KW KJacky LamHsu, Wan-LunWan-LunHsuPfeiffer, Ruth MRuth MPfeifferYu, Kelly JKelly JYuChan, Charles M LCharles M LChanLee, Vicky C TVicky C TLeeTSENG-CHENG CHENTerng, Shyuang-DerShyuang-DerTerngTsou, Yung-AnYung-AnTsouLeu, Yi-ShingYi-ShingLeuLiao, Li-JenLi-JenLiaoChang, Yen-LiangYen-LiangChangChien, Yin-ChuYin-ChuChienCHENG-PING WANGLin, Ching-YuanChing-YuanLinHua, Chun-HungChun-HungHuaLee, Jehn-ChuanJehn-ChuanLeeTSUNG-LIN YANGHsiao, Chu-HsingChu-HsingHsiaoMING-SHIANG WUTsai, Ming-HsuiMing-HsuiTsaiCheng, Hung-ChunHung-ChunChengHildesheim, AllanAllanHildesheimChen, Chien-JenChien-JenChenChan, K C AllenK C AllenChanLiu, ZhiweiZhiweiLiuCHIH-FENG LINCHUN-NAN CHEN etc.2023-11-082023-11-082023-09-100732183Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/636994Two Epstein-Barr virus (EBV)-based testing approaches have shown promise for early detection of nasopharyngeal carcinoma (NPC). Neither has been independently validated nor their performance compared. We compared their diagnostic performance in an independent population.en[SDGs]SDG3journal article10.1200/JCO.22.01979374783972-s2.0-85170111391https://api.elsevier.com/content/abstract/scopus_id/85170111391